What is the current Medical Device CDMO and CRO market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Medical Device CDMO and CRO market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Medical Device CDMO and CRO market?

Increasing demand for medical devices and outsourcing drive the market.

What are the major challenges in the Medical Device CDMO and CRO market?

Regulatory compliance and quality control are significant challenges.

Which regions are the leaders in the Medical Device CDMO and CRO market?

North America and Europe are the leading regions.

Who are the top companies in the Medical Device CDMO and CRO market?

Major players include Flex, Jabil, and Celestica.

What are the future opportunities in the Medical Device CDMO and CRO market?

Emerging markets and technological advancements offer growth opportunities.

How does technology impact the Medical Device CDMO and CRO market?

Advances in technology improve device development and manufacturing efficiency.

What is the current regulatory landscape for the Medical Device CDMO and CRO market?

Stringent regulations require compliance with FDA and EU guidelines.

What is the future outlook for the Medical Device CDMO and CRO market?

The market is expected to experience steady growth due to increasing demand.

Medical Device CDMO and CRO Trends, Opportunities & Forecast 2033

Medical Device CDMO and CRO by Type (/> Medical Device CDMO, Medical Device CRO), by Application (/> Cardiology, Diagnostic Imaging, Orthopedic, IVD, Ophthalmic, General and Plastic Surgery, Drug Delivery), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Device CDMO and CRO Market Overview

The Medical Device CDMO and CRO market refers to the industry of contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) that provide services to medical device companies. The Medical Device CDMO and CRO market size is estimated to be around $27.4 billion in 2025, with a growth outlook that is expected to be driven by the increasing demand for outsourcing services in the medical device industry. The market forecast suggests that the industry will expand at a CAGR of 10.3% from 2026 to 2033, driven by industry expansion and the growing need for specialized services such as design and development, testing, and regulatory affairs.

Loading chart…

The growth forecast for the Medical Device CDMO and CRO market is driven by several key forces, including technology shifts towards digitalization and automation, regulations such as the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), and consumer behavior trends such as the increasing demand for personalized and minimally invasive medical devices. The largest region for the Medical Device CDMO and CRO market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the growing demand for medical devices in countries such as China and India. Overall, the Medical Device CDMO and CRO market is expected to experience significant industry expansion over the forecast period, driven by the increasing demand for specialized services and the growing need for outsourcing in the medical device industry.

Report Overview

Report Attribute	Details
Market size value in 2025	123.40 million
Revenue forecast in 2033	225.04 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hitachi; Beckman; JEOL; Canon MEDICAL; Integer Holdings Corporation; ITL Group; Flexan(ILC Dover); SteriPack Group Ltd; TE Connectivity Ltd; Nortech Systems, Inc.; OSMUNDA Medical Device Service Group; Jabil Inc; Flex Healthcare Solutions; Sanmina; Nordson Medical; ELOS Medtech; CIRS Group; OSMUNDA MEDICAL DEVICE SERVICE GROUP.; Shanghai Hao Feng Medical Technology Co., Ltd.; Juyi Science and Technology (Shanghai) Co., Ltd.; Sanner Group; Wuhan Tacro Technology Co.,Ltd.; Lingboyihui; Huitong Medical; Hangzhou Tigermed Consulting Co.,Ltd.; Qingdao Novelbeam Technology Co.,ltd.; Shengen (Beijing) Pharmaceutical Technology Co., Ltd.; Medicalstrong (Beijing)Science and Technology Development Co., Ltd.; TechMax Technical Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Device CDMO and CRO market is poised for significant growth, driven by various factors that are reshaping the industry landscape. Understanding the dynamics of this market is crucial for stakeholders to navigate the opportunities and challenges that lie ahead.

Growth Drivers2 items

Increasing demand for outsourced services is driving the growth of the Medical Device CDMO and CRO market, as original equipment manufacturers (OEMs) focus on their core competencies and reduce costs. This trend is expected to contribute to the market's growth forecast, with the Medical Device CDMO and CRO market size anticipated to expand significantly over the next five years.

Advancements in medical technology are creating new opportunities for contract manufacturers and research organizations, enabling them to offer a broader range of services and capabilities to their clients, from product design and development to testing and commercialization.

Restraints2 items

Stringent regulatory requirements are a major restraint for the Medical Device CDMO and CRO market, as companies must comply with evolving laws and standards, such as those related to quality management, safety, and environmental sustainability. Failure to comply can result in significant fines, reputational damage, and loss of business.

High initial investment costs are a barrier to entry for new companies seeking to establish themselves in the Medical Device CDMO and CRO market, making it challenging for smaller players to compete with larger, more established firms that have greater resources and economies of scale.

Opportunities2 items

The growing demand for personalized medicine and customized medical devices is creating new opportunities for contract manufacturers and research organizations to develop and commercialize innovative products that meet the unique needs of individual patients. This trend is expected to drive growth in the Medical Device CDMO and CRO market size over the next few years.

Expansion into emerging markets is a key opportunity for companies in the Medical Device CDMO and CRO market, as these regions offer significant growth potential due to their large and growing populations, increasing healthcare spending, and rising demand for high-quality medical devices and services.

Challenges2 items

Managing supply chain risks is a major challenge for companies in the Medical Device CDMO and CRO market, as they must ensure the timely and cost-effective delivery of high-quality components and materials while minimizing the risk of disruptions, delays, and shortages. Effective supply chain management is critical to maintaining competitiveness and meeting customer needs.

Maintaining quality and compliance is an ongoing challenge for contract manufacturers and research organizations, as they must adhere to strict regulatory standards and guidelines while also meeting the evolving needs and expectations of their clients and customers. Failure to do so can result in significant consequences, including loss of business, reputational damage, and regulatory action.

Market Segmentation

Loading chart…

The Medical Device CDMO and CRO market can be segmented by Type, which includes contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). CDMOs provide development and manufacturing services for medical devices, while CROs offer research and development services. This segmentation contributes to the overall market size by highlighting the different services offered by companies in the industry.

Another important segmentation category is Application, which includes subtypes such as diagnostic devices, therapeutic devices, and surgical devices. This segmentation is crucial in understanding the Medical Device CDMO and CRO segmentation as it highlights the various areas where these services are applied. The application segmentation contributes to the overall market size by providing insights into the demand for CDMO and CRO services in different medical device categories.

Medical Device CDMO and CRO Segmentation Breakdown11 items

Type

/> Medical Device CDMO

Medical Device CRO

Application

/> Cardiology

Diagnostic Imaging

Orthopedic

IVD

Ophthalmic

General and Plastic Surgery

Drug Delivery

Regional Insights

Loading chart…

The Medical Device CDMO and CRO market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and the fastest-growing region, driven by increased adoption of medical devices, favorable policies, and investments in the healthcare sector. In North America, key drivers include demographics, infrastructure, and ecosystem maturity, with a regional forecast indicating a steady growth rate.

In Europe, the medical device CDMO and CRO market is driven by regulatory requirements, technological advancements, and partnerships between companies. Latin America's growth is driven by expanding healthcare infrastructure, government initiatives, and rising demand for medical devices. The Middle East & Africa region is expected to experience growth due to increasing investments in healthcare, growing population, and improving economy.

Regional Drivers5 items

Asia Pacific: increased adoption, favorable policies, investments

North America: demographics, infrastructure, ecosystem maturity

Europe: regulatory requirements, technological advancements, partnerships

Latin America: expanding healthcare infrastructure, government initiatives, rising demand

Middle East & Africa: increasing investments, growing population, improving economy

Competitive Landscape

The Medical Device CDMO and CRO competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on technology and service model to differentiate themselves, while local companies rely on channel strength and cost advantages. The Medical Device CDMO and CRO key players are focusing on regional expansion and innovation pipeline to stay competitive.

Companies in this market are adopting various strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay ahead. However, they face challenges like margin pressure, compliance costs, commoditization, and supply chain risks. To differentiate themselves, companies are focusing on technology, service model, and customization. The following companies are examples of this trend:

Hitachi: regional expansion

Beckman: innovation pipeline

JEOL: premium pricing

Canon MEDICAL: OEM tie-ups

Integer Holdings: vertical integration

ITL Group: local manufacturing

Key Medical Device CDMO and CRO Companies29 items

Hitachi

Beckman

JEOL

Canon MEDICAL

Integer Holdings Corporation

ITL Group

Flexan(ILC Dover)

SteriPack Group Ltd

TE Connectivity Ltd

Nortech Systems, Inc.

OSMUNDA Medical Device Service Group

Jabil Inc

Flex Healthcare Solutions

Sanmina

Nordson Medical

ELOS Medtech

CIRS Group

OSMUNDA MEDICAL DEVICE SERVICE GROUP.

Shanghai Hao Feng Medical Technology Co., Ltd.

Juyi Science and Technology (Shanghai) Co., Ltd.

Sanner Group

Wuhan Tacro Technology Co.,Ltd.

Lingboyihui

Huitong Medical

Hangzhou Tigermed Consulting Co.,Ltd.

Qingdao Novelbeam Technology Co.,ltd.

Shengen (Beijing) Pharmaceutical Technology Co., Ltd.

Medicalstrong (Beijing)Science and Technology Development Co., Ltd.

TechMax Technical Group

Market Ecosystem

The Medical Device CDMO and CRO ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream channels and end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where devices are designed, manufactured, and integrated; and downstream, where finished products are distributed and delivered to end users. Value is created and captured throughout this ecosystem as participants interact, exchange resources, and provide specialized services.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce medical devices

Technology providers — offer innovative solutions and platforms

System integrators / EPCs — integrate devices into larger systems

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish and enforce industry standards

Service providers / after-sales — offer maintenance and support services

In the Medical Device CDMO and CRO ecosystem, control points are primarily held by regulators and standards bodies, as well as large OEMs and manufacturers, who influence adoption through their specifications and procurement decisions. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact production timelines. Switching costs and partnerships are also critical, as companies may face significant expenses and interoperability requirements when changing suppliers or integrating new technologies. Furthermore, the ecosystem differs by region, with varying regulatory requirements and market conditions influencing the dynamics of value creation and capture in the Medical Device CDMO and CRO value chain analysis.

Recent Industry Insights

The Medical Device CDMO and CRO industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Foxconn, have focused on enhancing manufacturing capabilities and driving innovation. The industry has also seen notable mergers and acquisitions, including the acquisition of Creganna Medical by TE Connectivity, which has expanded the company's medical device portfolio.

Additionally, there have been several product launches and technology advancements, such as the introduction of advanced 3D printing techniques for medical devices. Regulatory changes, including updates to the EU's Medical Device Regulation, have also impacted the industry. Furthermore, the Medical Device CDMO and CRO industry has experienced a shift in consumer trends, with an increased focus on personalized medicine and digital health. Funding rounds and expansions, such as the investment in medical device manufacturing facilities, have also been prominent, driving growth and innovation in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Medical Device CDMO and CRO market outlook. The market exhibits high attractiveness due to increasing demand for outsourced services, driven by regulatory pressures and the need for specialized expertise. The competitive intensity is moderate, with key players focusing on strategic partnerships and capacity expansions to maintain market share.

The long-term outlook remains positive, with the innovation landscape expected to drive growth through advancements in digital technologies and medical device development. However, the demand–supply balance may be affected by key risk factors, including regulatory changes and supply chain disruptions. Overall, the Medical Device CDMO and CRO market outlook is favorable, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Medical Device CDMO and CRO Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Device CDMO and CRO Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Device CDMO and CRO Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Medical Device CDMO

6.1.2. Medical Device CRO

6.2. Global Medical Device CDMO and CRO Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Cardiology

6.2.2. Diagnostic Imaging

6.2.3. Orthopedic

6.2.4. IVD

6.2.5. Ophthalmic

6.2.6. General and Plastic Surgery

6.2.7. Drug Delivery

6.3. Global Medical Device CDMO and CRO Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Device CDMO and CRO Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Device CDMO and CRO Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Medical Device CDMO and CRO Market Competition by Key Manufacturers

8.1. Global Medical Device CDMO and CRO Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Device CDMO and CRO: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Hitachi

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Beckman

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. JEOL

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Canon MEDICAL

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Integer Holdings Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ITL Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Flexan(ILC Dover)

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. SteriPack Group Ltd

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. TE Connectivity Ltd

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Nortech Systems, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. OSMUNDA Medical Device Service Group

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Jabil Inc

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Flex Healthcare Solutions

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Sanmina

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Nordson Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. ELOS Medtech

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. CIRS Group

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. OSMUNDA MEDICAL DEVICE SERVICE GROUP.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Shanghai Hao Feng Medical Technology Co., Ltd.

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Juyi Science and Technology (Shanghai) Co., Ltd.

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Sanner Group

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Wuhan Tacro Technology Co.,Ltd.

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Lingboyihui

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Huitong Medical

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Hangzhou Tigermed Consulting Co.,Ltd.

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Qingdao Novelbeam Technology Co.,ltd.

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Shengen (Beijing) Pharmaceutical Technology Co., Ltd.

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Medicalstrong (Beijing)Science and Technology Development Co., Ltd.

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. TechMax Technical Group

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Device CDMO and CRO Market

Figure 4: Global Medical Device CDMO and CRO Market: Drivers

Figure 5: Global Medical Device CDMO and CRO Market: Challenges

Figure 6: Global Medical Device CDMO and CRO Market: Trends

Figure 7: Global Medical Device CDMO and CRO Market: Opportunity

Figure 8: Global Medical Device CDMO and CRO Market: Restraint

Figure 9: Global Medical Device CDMO and CRO Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Medical Device CDMO and CRO Market Value (USD Million) By Region

Figure 15: Global Medical Device CDMO and CRO Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Medical Device CDMO and CRO Market Value (USD Million) By Region

Figure 23: Global Medical Device CDMO and CRO Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Device CDMO and CRO Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Medical Device CDMO and CRO Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Medical Device CDMO and CRO Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Medical Device CDMO and CRO Market Value (USD Million) By Region

Table 10: Global Medical Device CDMO and CRO Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Medical Device CDMO and CRO Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Device CDMO and CRO Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Device CDMO and CRO Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Hitachi Basic Information And Sales Area

Table 31: Hitachi. Products Portfolio

Table 32: Beckman Basic Information And Sales Area

Table 33: Beckman. Products Portfolio

Table 34: JEOL Basic Information And Sales Area

Table 35: JEOL. Products Portfolio

Table 36: Canon MEDICAL Basic Information And Sales Area

Table 37: Canon MEDICAL. Products Portfolio

Table 38: Integer Holdings Corporation Basic Information And Sales Area

Table 39: Integer Holdings Corporation. Products Portfolio

Table 40: ITL Group Basic Information And Sales Area

Table 41: ITL Group. Products Portfolio

Table 42: Flexan(ILC Dover) Basic Information And Sales Area

Table 43: Flexan(ILC Dover). Products Portfolio

Table 44: SteriPack Group Ltd Basic Information And Sales Area

Table 45: SteriPack Group Ltd. Products Portfolio

Table 46: TE Connectivity Ltd Basic Information And Sales Area

Table 47: TE Connectivity Ltd. Products Portfolio

Table 48: Nortech Systems, Inc. Basic Information And Sales Area

Table 49: Nortech Systems, Inc.. Products Portfolio

Table 50: OSMUNDA Medical Device Service Group Basic Information And Sales Area

Table 51: OSMUNDA Medical Device Service Group. Products Portfolio

Table 52: Jabil Inc Basic Information And Sales Area

Table 53: Jabil Inc. Products Portfolio

Table 54: Flex Healthcare Solutions Basic Information And Sales Area

Table 55: Flex Healthcare Solutions. Products Portfolio

Table 56: Sanmina Basic Information And Sales Area

Table 57: Sanmina. Products Portfolio

Table 58: Nordson Medical Basic Information And Sales Area

Table 59: Nordson Medical. Products Portfolio

Table 60: ELOS Medtech Basic Information And Sales Area

Table 61: ELOS Medtech. Products Portfolio

Table 62: CIRS Group Basic Information And Sales Area

Table 63: CIRS Group. Products Portfolio

Table 64: OSMUNDA MEDICAL DEVICE SERVICE GROUP. Basic Information And Sales Area

Table 65: OSMUNDA MEDICAL DEVICE SERVICE GROUP.. Products Portfolio

Table 66: Shanghai Hao Feng Medical Technology Co., Ltd. Basic Information And Sales Area

Table 67: Shanghai Hao Feng Medical Technology Co., Ltd.. Products Portfolio

Table 68: Juyi Science and Technology (Shanghai) Co., Ltd. Basic Information And Sales Area

Table 69: Juyi Science and Technology (Shanghai) Co., Ltd.. Products Portfolio

Table 70: Sanner Group Basic Information And Sales Area

Table 71: Sanner Group. Products Portfolio

Table 72: Wuhan Tacro Technology Co.,Ltd. Basic Information And Sales Area

Table 73: Wuhan Tacro Technology Co.,Ltd.. Products Portfolio

Table 74: Lingboyihui Basic Information And Sales Area

Table 75: Lingboyihui. Products Portfolio

Table 76: Huitong Medical Basic Information And Sales Area

Table 77: Huitong Medical. Products Portfolio

Table 78: Hangzhou Tigermed Consulting Co.,Ltd. Basic Information And Sales Area

Table 79: Hangzhou Tigermed Consulting Co.,Ltd.. Products Portfolio

Table 80: Qingdao Novelbeam Technology Co.,ltd. Basic Information And Sales Area

Table 81: Qingdao Novelbeam Technology Co.,ltd.. Products Portfolio

Table 82: Shengen (Beijing) Pharmaceutical Technology Co., Ltd. Basic Information And Sales Area

Table 83: Shengen (Beijing) Pharmaceutical Technology Co., Ltd.. Products Portfolio

Table 84: Medicalstrong (Beijing)Science and Technology Development Co., Ltd. Basic Information And Sales Area

Table 85: Medicalstrong (Beijing)Science and Technology Development Co., Ltd.. Products Portfolio

Table 86: TechMax Technical Group Basic Information And Sales Area

Table 87: TechMax Technical Group. Products Portfolio

Table 88: Global Market Value (USD Million) (2025-2032) By Type

Table 89: Global Market Share (%) By Type (2032)

Table 90: Global Market Value (USD Million) (2025-2032) By Application

Table 91: Global Market Share (%) By Application (2032)

Table 92: Global Medical Device CDMO and CRO Market Value (USD Million) By Region

Table 93: Global Medical Device CDMO and CRO Market Share (%) By Region (2025-2032)

Table 94: North America Market Value (USD Million) (2025-2032) By Country

Table 95: North America Market Value (USD Million) (2025-2032) By Type

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: Europe Market Value (USD Million) (2025-2032) By Country

Table 98: Europe Market Value (USD Million) (2025-2032) By Type

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: South America Market Value (USD Million) (2025-2032) By Country

Table 104: South America Market Value (USD Million) (2025-2032) By Type

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Medical Device CDMO and CRO Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	123.40 million
Revenue forecast in 2033	225.04 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hitachi; Beckman; JEOL; Canon MEDICAL; Integer Holdings Corporation; ITL Group; Flexan(ILC Dover); SteriPack Group Ltd; TE Connectivity Ltd; Nortech Systems, Inc.; OSMUNDA Medical Device Service Group; Jabil Inc; Flex Healthcare Solutions; Sanmina; Nordson Medical; ELOS Medtech; CIRS Group; OSMUNDA MEDICAL DEVICE SERVICE GROUP.; Shanghai Hao Feng Medical Technology Co., Ltd.; Juyi Science and Technology (Shanghai) Co., Ltd.; Sanner Group; Wuhan Tacro Technology Co.,Ltd.; Lingboyihui; Huitong Medical; Hangzhou Tigermed Consulting Co.,Ltd.; Qingdao Novelbeam Technology Co.,ltd.; Shengen (Beijing) Pharmaceutical Technology Co., Ltd.; Medicalstrong (Beijing)Science and Technology Development Co., Ltd.; TechMax Technical Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Medical Device CDMO and CRO Segmentation Breakdown11 items

Type

/> Medical Device CDMO

Medical Device CRO

Application

/> Cardiology

Diagnostic Imaging

Orthopedic

IVD

Ophthalmic

General and Plastic Surgery

Drug Delivery

Regional Insights

Loading chart…

Regional Drivers5 items

Asia Pacific: increased adoption, favorable policies, investments

North America: demographics, infrastructure, ecosystem maturity

Europe: regulatory requirements, technological advancements, partnerships

Latin America: expanding healthcare infrastructure, government initiatives, rising demand

Middle East & Africa: increasing investments, growing population, improving economy

Competitive Landscape

Hitachi: regional expansion

Beckman: innovation pipeline

JEOL: premium pricing

Canon MEDICAL: OEM tie-ups

Integer Holdings: vertical integration

ITL Group: local manufacturing

Key Medical Device CDMO and CRO Companies29 items

Hitachi

Beckman

JEOL

Canon MEDICAL

Integer Holdings Corporation

ITL Group

Flexan(ILC Dover)

SteriPack Group Ltd

TE Connectivity Ltd

Nortech Systems, Inc.

OSMUNDA Medical Device Service Group

Jabil Inc

Flex Healthcare Solutions

Sanmina

Nordson Medical

ELOS Medtech

CIRS Group

OSMUNDA MEDICAL DEVICE SERVICE GROUP.

Shanghai Hao Feng Medical Technology Co., Ltd.

Juyi Science and Technology (Shanghai) Co., Ltd.

Sanner Group

Wuhan Tacro Technology Co.,Ltd.

Lingboyihui

Huitong Medical

Hangzhou Tigermed Consulting Co.,Ltd.

Qingdao Novelbeam Technology Co.,ltd.

Shengen (Beijing) Pharmaceutical Technology Co., Ltd.

Medicalstrong (Beijing)Science and Technology Development Co., Ltd.

TechMax Technical Group

Market Ecosystem

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce medical devices

Technology providers — offer innovative solutions and platforms

System integrators / EPCs — integrate devices into larger systems

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish and enforce industry standards

Service providers / after-sales — offer maintenance and support services

Recent Industry Insights

Analyst Overview

Table of Contents